Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Frequent snacks are linked to a higher risk of recurrent respiratory tract infections in preschoolers, according to a meta-analysis of global studies.
Proton pump inhibitors (PPIs) can cause drug-related problems in hospitalized patients with kidney disease, including issues with drug selection, treatment duration, and…
Yes, asthma significantly increases a preschooler's risk of recurrent respiratory tract infections, with meta-analysis showing about 3 times higher odds.
Yes, passive smoking is a significant risk factor that increases the likelihood of recurrent respiratory tract infections in young children.
Yes, longitudinal TCR profiling can predict GVHD in stem cell transplant patients, with studies showing AUC values around 0.83 for GVHD prediction.
Having a fungal infection in your lungs does not automatically mean you have a bacterial infection, though both can occur together in certain conditions like HIV or COPD.
Researchers use mice and rats with diet-induced obesity, heart attacks, or specific genetic changes to study cardiometabolic diseases like heart failure and diabetes.
Researchers induce cardiometabolic disease in mice primarily by feeding them a high-fat diet, often combined with chemical treatments like VCD to mimic postmenopausal states.
In mice with diet-induced cardiometabolic disease, intermuscular fat tissue shows specific gene signatures involving inflammation, extracellular matrix changes, and metabolic…
Cognitive remediation therapy (CRT) shows significant benefits over standard care for people with psychotic disorders, improving global functioning and quality of life.
The pooled overall complication rate for Thulium Fiber Laser lithotripsy is about 10.4%, with major complications (Clavien-Dindo III-V) occurring in about 1.2% of cases.
Yes, in a real-world study, camrelizumab was linked to a higher risk of disease progression and death than pembrolizumab in nonsquamous NSCLC, especially in later lines of therapy.
Liver-directed therapy combined with immune checkpoint inhibitors appears most effective; tebentafusp is approved for HLA-A*02:01+ patients; other options include…
Yes, a case report describes a patient with metastatic uveal melanoma who achieved durable disease control after adding SBRT to tebentafusp, with a partial response and 35 months…
Prolgolimab plus chemotherapy showed the strongest overall survival benefit in a 2025 phase III trial, while network meta-analysis also ranked pembrolizumab and cemiplimab plus…
Genetic factors increase a child's risk of chronic otitis media by altering immune system responses and middle ear function, with specific gene variants on chromosome 19…
Yes, bone conduction hearing devices significantly improve health-related quality of life for adults with chronic otitis media, based on systematic reviews and clinical studies.
Yes, a case report shows tebentafusp plus SBRT controlled metastatic uveal melanoma for over 35 months, but more research is needed to confirm this approach.
Immunoembolization shows lower disease control rates than the FOCUS trial for liver-dominant metastatic uveal melanoma, though tebentafusp combined with radiotherapy may offer…
A meta-analysis found no significant difference in hospital length of stay between high-dose and low-dose ceftriaxone for non-CNS infections.
ATRA plus ATO for APL achieves 3-year overall survival of 95% and 10-year survival of ≥80%, with complete remission rates over 95%.
An AI tool shows very high accuracy for distinguishing Acute Promyelocytic Leukemia (APL) from other leukemias, with an AUROC of 0.98 in international tests, though it currently…
Frontline ATRA-ATO therapy is highly effective for newly diagnosed APL, with complete remission rates over 94% and 3-year survival above 93% in clinical trials.
Yes, the rate of oral and pharyngeal HPV-associated cancer increased in the US between 2007 and 2016, likely driven by rising HPV-related cases.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.